Catena Biosciences

Catena Biosciences develops protein- and cell-based therapies via enzyme-based protein-to-protein attachment. The company’s technology can conjugate any two soluble proteins together — including large, complex proteins not suitable for traditional approaches — without extensive modification. Catena can also vary which attachment sites are used and how much attachment occurs to customize therapies.